RoslinCT, a leading global cell therapy Contract Development and Manufacturing Organization, today announced a strategic partnership with BlueRock Therapeutics, a leader in stem cell therapeutic ...

MAIA recently announced that it has completed international enrollment in Part C of the Phase 2 THIO-101 expansion trial. Treatment with ateganosine followed by cemiplimab has shown an acceptable ...

FUJIFILM Biotechnologies (Fujifilm), a world-leading contract development and manufacturing organization (CDMO) for biologics ...

A new genetic screening method allows researchers to efficiently modulate individual genes across entire tissues and provides ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Getting it over the finish line was a labor of love—and now, more than five years after her death, the lab of former Sloan ...

Scientists say they have built a cell from scratch for the first time that can feed, grow and replicate like a natural cell.

Sartorius and LFB Biomanufacturing expand their CDMO partnership, integrating engineered CHO cell lines with GMP manufacturing capabilities.

Scientists say they have built a cell from scratch for the first time that feeds, grows and replicates like a natural cell, a ...

Korea’s National Stem Cell Bank will begin distributing clinical-grade induced pluripotent stem cells (iPSCs) to researchers and biotech firms later this month, a move expected to significantly lower ...